| [1] |
Sarin S K, Choudhury A, Kumar A, et al. Acute-on-chronic liver failure: Pathophysiological mechanisms and clinical management[J]. Nat Rev Gastroenterol Hepatol, 2026, 23( 5): 411- 431. DOI: 10.1038/s41575-025-01159-4. |
| [2] |
Chen T, Yang Z Y, Choudhury A K, et al. Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: A multi-national study from the Asia-Pacific region[J]. Hepatol Int, 2019, 13( 6): 695- 705. DOI: 10.1007/s12072-019-09992-x. |
| [3] |
Zaccherini G, Weiss E, Moreau R. Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment[J]. JHEP Rep, 2021, 3( 1): 100176. DOI: 10.1016/j.jhepr.2020.100176. |
| [4] |
Lin S L, Wang X M, Xu Z X, et al. Construction of a prediction model for hepatic encephalopathy in acute-on-chronic liver failure patients[J]. Ann Med, 2024, 56( 1): 2410403. DOI: 10.1080/07853890.2024.2410403. |
| [5] |
Chen Keng, Li Pinghong, Li Yanling, et al. The clinical features and prognostic determinates of patients with hepatitis B related acute-on-chronic liver failure complicated with hepatic encephalopathy[J]. Chin Hepatol, 2023, 28( 5): 568- 571, 580. DOI: 10.3969/j.issn.1008-1704.2023.05.018. |
| [6] |
Mishra A K, Dhiman R K. Hepatic encephalopathy in cirrhosis: Therapies and developments[J]. Metab Brain Dis, 2025, 40( 5): 198. DOI: 10.1007/s11011-025-01598-7. |
| [7] |
Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of hepatic encephalopathy in cirrhosis(2024)[J]. Chin J Hepatol, 2024, 32( 9): 799- 812. DOI: 10.3760/cma.j.cn501113-20240630-00309. |
| [8] |
Gluud L L, Vilstrup H, Morgan M Y. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis[J]. Cochrane Database Syst Rev, 2016, 2016( 5): CD003044. DOI: 10.1002/14651858.CD003044.pub4. |
| [9] |
Kibble H, Shawcross D L. The assessment and management of cirrhotic patients with encephalopathy[J]. United European Gastroenterol J, 2024, 12( 2): 187- 193. DOI: 10.1002/ueg2.12530. |
| [10] |
Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2024version)[J]. J Clin Hepatol, 2024, 40( 12): 2371- 2387. DOI: 10.12449/JCH241206. 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2024年版)[J]. 临床肝胆病杂志, 2024, 40( 12): 2371- 2387. DOI: 10.12449/JCH241206. |
| [11] |
Sarin S K, Choudhury A, Sharma M K, et al. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the Study of the Liver(APASL): An update[J]. Hepatol Int, 2019, 13( 4): 353- 390. DOI: 10.1007/s12072-019-09946-3. |
| [12] |
European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatic encephalopathy[J]. J Hepatol, 2022, 77( 3): 807- 824. DOI: 10.1016/j.jhep.2022.06.001. |
| [13] |
Vidal-Cevallos P, Chávez-Tapia N C, Uribe M. Current approaches to hepatic encephalopathy[J]. Ann Hepatol, 2022, 27( 6): 100757. DOI: 10.1016/j.aohep.2022.100757. |
| [14] |
Xu X Y, Ding H G, Li W G, et al. Chinese guidelines on the management of hepatic encephalopathy in cirrhosis(2024)[J]. J Clin Transl Hepatol, 2025, 13( 3): 253- 267. DOI: 10.14218/JCTH.2024.00484. |
| [15] |
Premkumar M, Saxena P, Rangegowda D, et al. Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute-on-chronic liver failure: An observational cohort study[J]. Liver Int, 2019, 39( 4): 694- 704. DOI: 10.1111/liv.14034. |
| [16] |
Sharma S, Agarwal S, Saraya A, et al. Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: A propensity score matched study from the APASL ACLF Research Consortium(AARC)[J]. Hepatol Int, 2022, 16( 5): 1234- 1243. DOI: 10.1007/s12072-022-10372-1. |
| [17] |
Li Xue, Zhang Liang, Wang Xiao, et al. Research progress of coagulation function monitoring in the diagnosis and treatment of acute-on-chronic liver failure[J]. Chin Hepatol, 2023, 28( 2): 247- 249. DOI: 10.14000/j.cnki.issn.1008-1704.2023.02.016. |
| [18] |
National Clinical Research Center for Infectious Diseases; Society of Hepatology, Beijing Medical Association; Translational Medicine Branch, Chinese Association of Gerontology and Geriatrics. Expert consensus on the clinical diagnosis and treatment of coagulation disorders related to liver disease[J]. Chin J Hepatol, 2026, 34( 5): 417- 429. DOI: 10.3760/cma.j.cn501113-20260203-00055. |
| [19] |
Chen Zhili, Xie Qing, Mo Ruidong. Application and evaluation of TIPS in patients with acute-on-chronic liver failure at high risk of variceal rebleeding[J]. Chin Hepatol, 2024, 29( 5): 596- 599. DOI: 10.14000/j.cnki.issn.1008-1704.2024.05.024. |
| [20] |
Du Bingyu, Li Junfeng, Zhang Liting. Early diagnosis and treatment of patients with acute-on-chronic liver failure complicated with acute kidney injury[J]. J Pract Hepatol, 2025, 28( 5): 797- 800. DOI: 10.3969/j.issn.1672-5069.2025.05.040. |
| [21] |
Pose E, Piano S, Juanola A, et al. Hepatorenal syndrome in cirrhosis[J]. Gastroenterology, 2024, 166( 4): 588- 604. DOI: 10.1053/j.gastro.2023.11.306. |
| [22] |
Weinberg E M, Wong F, Vargas H E, et al. Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin[J]. Liver Transpl, 2024, 30( 4): 347- 355. DOI: 10.1097/LVT.0000000000000277. |
| [23] |
Maiwall R, Singh S P, Angeli P, et al. APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure[J]. Hepatol Int, 2024, 18( 3): 833- 869. DOI: 10.1007/s12072-024-10650-0. |
| [24] |
Zarbock A, Kellum J A, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: The ELAIN randomized clinical trial[J]. JAMA, 2016, 315( 20): 2190- 2199. DOI: 10.1001/jama.2016.5828. |
| [25] |
Liu Wanshu, Shen Lijun, He Xi, et al. Effects of ascites grading and the application of non-selective beta-blockers on the 1-year prognosis of acute-on-chronic liver failure[J]. Chin J Hepatol, 2025, 33( 1): 57- 62. DOI: 10.3760/cma.j.cn501113-20240130-00067. |
| [26] |
Xu M M, Kong M, Yu P F, et al. Acute-on-chronic liver failure defined by Asian Pacific association for the study of the liver should include decompensated cirrhosis[J]. Front Med, 2021, 8: 750061. DOI: 10.3389/fmed.2021.750061. |
| [27] |
Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J]. Gastroenterology, 2013, 144( 7): 1426- 1437. DOI: 10.1053/j.gastro.2013.02.042. |
| [28] |
Abraldes J G, Caraceni P, Ghabril M, et al. Update in the treatment of the complications of cirrhosis[J]. Clin Gastroenterol Hepatol, 2023, 21( 8): 2100- 2109. DOI: 10.1016/j.cgh.2023.03.019. |
| [29] |
Singh V, De A, Mehtani R, et al. Asia-Pacific association for study of liver guidelines on management of ascites in liver disease[J]. Hepatol Int, 2023, 17( 4): 792- 826. DOI: 10.1007/s12072-023-10536-7. |
| [30] |
Lan T, Chen M, Tang C W, et al. Recent developments in the management of ascites in cirrhosis[J]. United European Gastroenterol J, 2024, 12( 2): 261- 272. DOI: 10.1002/ueg2.12539. |
| [31] |
Wong F, Vagas H E, Reddy K R, et al. The effects of alfapump on ascites control and quality of life in patients with cirrhosis and recurrent or refractory ascites[J]. Am J Gastroenterol, 2025, 120( 10): 2291- 2301. DOI: 10.14309/ajg.0000000000003300. |
DownLoad: